NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023-Reference-Cited by-全球学者库

NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023

Published:2023-04 Issue:4 Volume:21 Page:340-350
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Ettinger David S.¹,Wood Douglas E.²,Aisner Dara L.³,Akerley Wallace⁴,Bauman Jessica R.⁵,Bharat Ankit⁶,Bruno Debora S.⁷,Chang Joe Y.⁸,Chirieac Lucian R.⁹,DeCamp Malcolm¹⁰,Dilling Thomas J.¹¹,Dowell Jonathan¹²,Durm Gregory A.¹³,Gettinger Scott¹⁴,Grotz Travis E.¹⁵,Gubens Matthew A.¹⁶,Hegde Aparna¹⁷,Lackner Rudy P.¹⁸,Lanuti Michael¹⁹,Lin Jules²⁰,Loo Billy W.²¹,Lovly Christine M.²²,Maldonado Fabien²²,Massarelli Erminia²³,Morgensztern Daniel²⁴,Ng Thomas²⁵,Otterson Gregory A.²⁶,Patel Sandip P.²⁷,Patil Tejas³,Polanco Patricio M.¹²,Riely Gregory J.²⁸,Riess Jonathan²⁹,Schild Steven E.¹⁵,Shapiro Theresa A.¹,Singh Aditi P.³⁰,Stevenson James⁷,Tam Alda⁸,Tanvetyanon Tawee¹¹,Yanagawa Jane³¹,Yang Stephen C.¹,Yau Edwin³²,Gregory Kristina M.³³,Hughes Miranda³³

Affiliation:

1. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

2. Fred Hutchinson Cancer Center

3. University of Colorado Cancer Center

4. Huntsman Cancer Institute at the University of Utah

5. Fox Chase Cancer Center

6. Robert H. Lurie Comprehensive Cancer Center of Northwestern University

7. Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

8. The University of Texas MD Anderson Cancer Center

9. Dana-Farber/Brigham and Women’s Cancer Center

10. University of Wisconsin Carbone Cancer Center

11. Moffitt Cancer Center

12. UT Southwestern Simmons Comprehensive Cancer Center

13. Indiana University Melvin and Bren Simon Comprehensive Cancer Center

14. Yale Cancer Center/Smilow Cancer Hospital

15. Mayo Clinic Comprehensive Cancer Center

16. UCSF Helen Diller Family Comprehensive Cancer Center

17. O’Neal Comprehensive Cancer Center at UAB

18. Fred & Pamela Buffett Cancer Center

19. Massachusetts General Hospital Cancer Center

20. University of Michigan Rogel Cancer Center

21. Stanford Cancer Institute

22. Vanderbilt-Ingram Cancer Center

23. City of Hope National Medical Center

24. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

25. The University of Tennessee Health Science Center

26. The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

27. UC San Diego Moores Cancer Center

28. Memorial Sloan Kettering Cancer Center

29. UC Davis Comprehensive Cancer Center

30. Abramson Cancer Center at the University of Pennsylvania

31. UCLA Jonsson Comprehensive Cancer Center

32. Roswell Park Comprehensive Cancer Center

33. National Comprehensive Cancer Network

Abstract

The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) provide recommendations for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus on neoadjuvant and adjuvant (also known as perioperative) systemic therapy options for eligible patients with resectable NSCLC.

Publisher

Harborside Press, LLC

Subject

Oncology

Link

https://jnccn.org/downloadpdf/journals/jnccn/21/4/article-p340.xml

Reference31 articles.

1. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma;Govindan R,2022

2. Recent clinical advances in lung cancer management;Johnson DH,2014

3. Management of non-small-cell lung cancer: recent developments;Reck M,2013

4. Targeted therapy for non-small-cell lung cancer: past, present and future;Forde PM,2013

5. Ten years of progress in non-small cell lung cancer;Ettinger DS,2012

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 18F-FDG PET/CT characteristics of IASLC grade 3 invasive adenocarcinoma and the value of 18F-FDG PET/CT for preoperative prediction: a new prognostication model;Nuclear Medicine Communications;2024-02-05

2. USP32 facilitates non-small cell lung cancer progression via deubiquitinating BAG3 and activating RAF-MEK-ERK signaling pathway;2024-02-05

3. Tumor-associated macrophages in non-small-cell lung cancer: from treatment resistance mechanisms to therapeutic targets;Critical Reviews in Oncology/Hematology;2024-02

4. USP7-mediated ERβ stabilization mitigates ROS accumulation and promotes osimertinib resistance by suppressing PRDX3 SUMOylation in non-small cell lung carcinoma;Cancer Letters;2024-02

5. Identification and characterization of CLEC11A and its derived immune signature in gastric cancer;Frontiers in Immunology;2024-01-29